in f

We are NTP Nano Tech Projects srl

NTP Nano Tech Projects srl is a young italian company based in the Marche region, in the city of Sant'Angelo in Vado(Pesaro-Urbino), which operates in the biotechnology and nanotechnology sectors.

In particular, NTP is oriented towards research and development, as well as the creation of solutions and products for optical detection in the biomedical field.

The general project promoted by NTP has the ambition both to support and encourage new processes of reorganization and optimization of healthcare facilities, and to generate a transversal social impact that aims to improve the living conditions of the community, understood in the broadest and most global sense.

Our History

  • The idea

    Beginning of designing an high sensitivity optical instrument capable of detecting a wider number of molecular targets than conventional systems.

  • The foundation

    NTP Nano Tech Projects s.r.l. founded in Sant'Angelo in Vado (Marche region - Italy).

  • The first Nano Eye Device (NED)

    Releasing of the first Nano Eye Device(NED) proof of concept for virus detection.

    Italian patent application filed.

  • The innovation

    International Patent Application (PTC) filed.

    Integration of ICT functionality in the Nano Eye Device.

    Evolution of the Nano Eye Device into "Smart Microscope" and new application in Digital Pathology (DP).

  • The NED project

    Italian patent granted.

    EU project - H2020 SMEINST Phase 1 grant ad.

    Start of the Digital Pathology and Molecular Diagnostics projects.

    NTP recognized as the first italian innovative startup with a social vocation.

  • The progress

    International Patent Application (PCT) published by World Intellectual Property Organization (WIPO) in Digital Pathology.

    Releasing of the first NED Digital Pathology prototype.

    NTP got a substantial equity capital (seed) from the most important italian BA, Italian Angels for Growth(IAG).

    Beginning of clinical validation on digital pathology at the Trento Hospital and the Humanitas Research Hospital.

  • The molecular diagnostics

    Releasing of the first NED Virus Detection prototype.

    Beginning of the design of the molecular diagnostics process at the University of Urbino on HPV test cases.

    NTP recognized as Innovative SME.

  • The growth

    Second investment by Italian Angels for Growth (IAG).

    Investment by Trentino Sviluppo.

    Opening of a second office in Rovereto (Trento - Italy).

    Releasing of the second NED-VD prototype with better performance.

    Patent granted in USA, Japan and Singapore.

  • The determination

    Beginning of clinical validation of molecular diagnostics process at the University of Pavia (San Matteo) on test cases to detect high-risk HPV (HPV16), full tests on human samples.

  • Today

    Start of the new molecular diagnostics project for the detection of Sars-Cov2.

    Patent granted in the EU.

    CE-IVD certification for NED-DP obtained.

Our History

  • The idea

    Beginning of designing an high sensitivity optical instrument capable of detecting a wider number of molecular targets than conventional systems.

  • The foundation

    NTP Nano Tech Projects s.r.l. founded in Sant'Angelo in Vado (Marche region - Italy).

  • The first Nano Eye Device (NED)

    Releasing of the first Nano Eye Device(NED) proof of concept for virus detection.

    Italian patent application filed.

  • The innovation

    International Patent Application (PTC) filed.

    Integration of ICT functionality in the Nano Eye Device.

    Evolution of the Nano Eye Device into "Smart Microscope" and new application in Digital Pathology (DP).

  • The NED project

    Italian patent granted.

    EU project - H2020 SMEINST Phase 1 grant ad.

    Start of the Digital Pathology and Molecular Diagnostics projects.

    NTP recognized as the first italian innovative startup with a social vocation.

  • The progress

    International Patent Application (PCT) published by World Intellectual Property Organization (WIPO) in Digital Pathology.

    Releasing of the first NED Digital Pathology prototype.

    NTP got a substantial equity capital (seed) from the most important italian BA, Italian Angels for Growth(IAG).

    Beginning of clinical validation on digital pathology at the Trento Hospital and the Humanitas Research Hospital.

  • The molecular diagnostics

    Releasing of the first NED Virus Detection prototype.

    Beginning of the design of the molecular diagnostics process at the University of Urbino on HPV test cases.

    NTP recognized as Innovative SME.

  • The growth

    Second investment by Italian Angels for Growth (IAG).

    Investment by Trentino Sviluppo.

    Opening of a second office in Rovereto (Trento - Italy).

    Releasing of the second NED-VD prototype with better performance.

    Patent granted in USA, Japan and Singapore.

  • The determination

    Beginning of clinical validation of molecular diagnostics process at the University of Pavia (San Matteo) on test cases to detect high-risk HPV (HPV16), full tests on human samples.

  • Today

    Start of the new molecular diagnostics project for the detection of Sars-Cov2.

    Patent granted in the EU.

    CE-IVD certification for NED-DP obtained.

+ -

Our Vision

NTP would be a great protagonist in the development and integration of specialized solutions with high-tech and innovation content, designed to support the social needs and new global policies in constant evolution in areas such as Health and Scientific Research, where raised more and more services distributed in a widespread and transverse way, easily usable by a large number of connected operators, so as to realize at the end a widespread benefit to the greatest number of people.

Our Mission

Provide a direct and fast access to the mysterious and unlimited world of the non-visible, with the aim both to establish relationships and interpretations respect to the macroscopic world, and to support the virtuous global effect of growth of knowledge and awareness, so the widespread adoption of behaviors in order to improve the lifestyle and the sensitivity for the care of ourself and others.

Our Values

The Ethics.
We create and share, internally and with our partners, long-term value through our commitment to improve, innovate, sustain and develop our solutions and care of our people.
The Excellent.
We want to support our products end-user, working with a big commitment to the satisfaction of their specialized needs and creating solutions and products with high technlogical and social content.

Institutional

Our quality policy
Read
Our code of conduct
Read
Certification ISO 13485:2016
Read
Our code of ethics
Read

Our Team

ING.
MASSIMO GALAVOTTI

Chief Executive Officer

ING.
GIANLUCA MARONCELLI

Chairman of the Board

MAURO ANDREA MALAN

Sales & Marketing Manager

PH.D
ADOLFO CARLONI

Scientific Director

ING.
PAOLO B GIORDANO

Chief Information Officer

MATHIAS AMATORI

Junior Software Engineer

DR.
NANCY PARISI

UI/UX Junior Designer

DR.
LUCIA GREGORI

Project Manager

DR.
SARA PISELLI

Biology Specialist

PH.D
ROBERTO LO SAVIO

Chief Technology Officer

DR.
ALESSANDRO PENNESI

Biology Specialist

DR.
WILLIAM WARNOTS

Business Management

Join our group!

We are hiring! Take a look at the section dedicaed to open positions and contact us.